2-238848570-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PP5_Moderate
The NM_001271893.4(TWIST2):c.355C>T(p.Gln119Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000569 in 1,582,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000042 ( 0 hom. )
Consequence
TWIST2
NM_001271893.4 stop_gained
NM_001271893.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
TWIST2 (HGNC:20670): (twist family bHLH transcription factor 2) The protein encoded by this gene is a basic helix-loop-helix type transcription factor and shares similarity with Twist. This protein may inhibit osteoblast maturation and maintain cells in a preosteoblast phenotype during osteoblast development. This gene may be upregulated in certain cancers. Mutations in this gene cause focal facial dermal dysplasia 3, Setleis type. Two transcript variants encoding the same protein have been found. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 2-238848570-C-T is Pathogenic according to our data. Variant chr2-238848570-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 30678.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TWIST2 | NM_001271893.4 | c.355C>T | p.Gln119Ter | stop_gained | 1/2 | ENST00000612363.2 | |
TWIST2 | NM_057179.3 | c.355C>T | p.Gln119Ter | stop_gained | 1/2 | ||
TWIST2 | XR_007069137.1 | n.486C>T | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TWIST2 | ENST00000612363.2 | c.355C>T | p.Gln119Ter | stop_gained | 1/2 | 1 | NM_001271893.4 | P1 | |
TWIST2 | ENST00000448943.2 | c.355C>T | p.Gln119Ter | stop_gained | 1/2 | 1 | P1 | ||
TWIST2 | ENST00000710607.1 | c.355C>T | p.Gln119Ter | stop_gained | 1/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000996 AC: 2AN: 200756Hom.: 0 AF XY: 0.00000926 AC XY: 1AN XY: 107968
GnomAD3 exomes
AF:
AC:
2
AN:
200756
Hom.:
AF XY:
AC XY:
1
AN XY:
107968
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000419 AC: 6AN: 1430430Hom.: 0 Cov.: 31 AF XY: 0.00000282 AC XY: 2AN XY: 709084
GnomAD4 exome
AF:
AC:
6
AN:
1430430
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
709084
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74364
GnomAD4 genome
AF:
AC:
3
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Focal facial dermal dysplasia type III Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 13, 2010 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 30, 2023 | Published functional studies demonstrate that Q119X has a reduced ability to act as a transcription factor (Franco et al., 2011).; Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 42 amino acids are lost; This variant is associated with the following publications: (PMID: 21801849, 20437613, 14069095, 20691403) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at